CSSN: ISSN 1000-467X CODEN: AIZHENG4 CN: 44-1195/R

CJC is published 12 times a year.

Sign up for Table of Contents Alerts!

home subscribe search archive forthcoming

Please note: CJC is published in English and Chinese. Manuscripts are published online prior to printing. The citation will change as volume, issue and page numbers are finalized.

Email this page Print this page

Basic Research Paper

Effects of Manumycin Combined with Methoxyamine on Apoptosis in Myeloid Leukemia U937 Cells

Miao-Rong She, Kun-Yuan Guo, Xin-Qing Niu and Xiao-Xun Lu

volume 27 | issue 8

August 2008
Pages: 140 - 143

Purchase article for $19

Subscribe to this journal for $0/year

Background and Objective: Repair of DNA damage is important to cell survival. Our previous study showed DNA damage response induced by manumycin in cancer cells. We hypothesized that methoxyamine, an inhibitor of base-excision repair, can enhance the antineoplastic effect of manumycin. This study was to investigate apoptosis induced by manucycin combined with methoxyamine in myeloid leukemia cell line U937, and to explore the role of mitochondrial apoptotic pathway in apoptosis induction of the two drugs. Methods: U937 cells were treated with various concentrations of manumycin and/or methoxyamine for 48 h. The cell viability was analyzed by MTT assay. Colony formation was evaluated by soft agar clonogenic assay. Cell apoptosis was investigated by flow cytometry. Protein expressions of cytochrome c, caspase-9, and poly ADP-ribose polymerase (PARP) were determined by Western blot. Results: The dose-response curve of manumycin was shifted to the left after addition of methoxyamine. The combination index (CI) was less than 1 in U937 cells (p < 0.05), indicating a synergistic effect of manumycin and methoxyamine. Rates of colony formation of U937 cells treated with 1µmol/L manumycin, or 5 mmol/L methoxyamine, or the combination of the two were 0.3641 ± 0.0463, 0.7541 ± 0.0379, and 0.0473 ± 0.0024, respectively compared with that of control cells (p < 0.05). Moreover, the drug combination resulted in enhanced apoptosis in U937 cells. The apoptotic rates of the control, manumycin, methoxyamine and combination group were (2.34 ± 0.30)%, (8.80 ± 0.95)%, (2.21 ± 0.19)% and (13.37 ± 0.91)%, respectively. The combination of manumycin with methoxyamine also promoted the release of cytochrome c from mitochondria into the cytosol, activated caspase-9, and led to appearance of specific cleavage of PARP in U937 cells. Conclusion: Methoxyamine enhances manumycin-induced apoptosis in U937 myeloid leukemia cells.

Authors

Miao-Rong She

Zhujiang Hospital; Southern Medical University

Kun-Yuan Guo

Zhujiang Hospital; Southern Medical University

Xin-Qing Niu

Zhujiang Hospital; Southern Medical University

Xiao-Xun Lu

Zhujiang Hospital; Southern Medical University


Purchase article for $19

Subscribe to this journal for $0/year